- PLN101.67m
- PLN94.05m
Brief: Nanogroup Divests Its Own Stake
Brief: Nanogroup To Buy 2.1 Mln Own Shares For Total Of 2.2 Mln Zlotys
Brief: NanoGroup Acquires 10.44% Of Own Stake
Brief: Tomasz Ciach Lowers Stake In NANOGROUP To 5.13%
Brief: Tomasz Ciach Lowers His Stake In Nanogroup To 13.43%
Brief: Nanogroup Unit Gets Results On System Of Organ Perfusion Intended For Transplant
Brief: Nanogroup EGM To Vote On Issue Of Series B Subscription Warrants
Brief: Nanogroup Appoints Przemyslaw Mazurek As New CEO
Brief: Nanogroup's Shareholder Offers To Divest 3.4 Mln Of Company Shares For Free
Brief: Nanogroup Unit Gets Positive Results Of Ex-Vivo Studies On Drug Candidate For Ovary Cancer
Brief: Nanogroup Unit Updates On Test Results For Ovarian Cancer Drug Candidate PolEpi
Brief: NanoGroup Says Unit's Report Shows Swine Kidney Remains Transplantable After Perfusion Tests Using NanOX10
Brief: Nanogroup Appoints Piotr Mierzejewski As CEO As Of Feb 25
Brief: Nanogroup CEO Marek Borzestowski Resigns From Management Board As Of Feb 24
Brief: Nanogroup 9-Month Net Result Turns to Loss Of 175,596 Zlotys
Brief: Nanogroup Unit Gets Recommendation For Financing From Polish National Centre Of R&D
Brief: NanoGroup Says Q3 Commission From Marion From Sales Of Inventi Mask And FFP2 Inventi At 0.1 Mln Zlotys
Brief: Nanogroup Says Polish Financial Regulator Suspends Trading In Company's Shares
Brief: Nanogroup Q1 Net Loss Widens To 10,822 Zlotys